MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Friday reported a loss of $9 million in its third quarter.
On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 84 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.
Trillium shares have increased 55 percent since the beginning of the year. The stock has increased 16 percent in the last 12 months.